e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Pulmonary vascular diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP
O. Hilberg, C. U. Andersen, S. Mellemkjær, J. E. Nielsen-Kudsk, B. E. Laursen, U. Simonsen (Arhus, Denmark)
Source:
Annual Congress 2009 - Pulmonary vascular diseases
Session:
Pulmonary vascular diseases
Session type:
Thematic Poster Session
Number:
3858
Disease area:
Airway diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Hilberg, C. U. Andersen, S. Mellemkjær, J. E. Nielsen-Kudsk, B. E. Laursen, U. Simonsen (Arhus, Denmark). Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP. Eur Respir J 2009; 34: Suppl. 53, 3858
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Accuracy of echocardiography to detect pulmonary hypertension in severe COPD
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
NT-proBNP in assessment of pulmonary hypertension in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Prevalence of pulmonary hypertension among outpatients with sarcoidosis: An echocardiographic and pulmonary catheterization study
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012
Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD
Source: Eur Respir J 2001; 17: 350-355
Year: 2001
CT predictors of pulmonary hypertension in patients with severe COPD
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018
The role of echocardiography in the diagnosis and management of patients with pulmonary hypertension
Source: Eur Respir Rev 2010 19: 288-299
Year: 2010
Prevalence of established and exercise induced pulmonary hypertension in COPD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Usefulness of FVC/DLCO ratio to stratify the risk of mortality in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension
Source: Eur Respir J, 50 (3) 1700784; 10.1183/13993003.00784-2017
Year: 2017
Diagnosis and treatment of secondary pulmonary hypertension in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 404s
Year: 2006
Pulmonary hypertension in COPD: Prevalence and characteristics
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications
Source: International Congress 2015 – COPD: notable points
Year: 2015
Acquisition of echo-Doppler parameters of pulmonary hypertension in COPD
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Does pulmonary hypertension exclude pulmonary rehabilitation in patients with COPD?
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Prevalence of pulmonary hypertension in patients undergo hemodialysis
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept